Humoral Immunogenicity to a Second and Third Dose of Covid-19 Vaccine Bnt162b2 in Patients with Spondyloarthritis Receiving Secukinumab: A Prospective Study

Elkayam, O.; Eviatar, T.; Paran, D.; Levartovsky, D.; Kaufman, I.; Broyde, A.; Elalouf, O.; Polachek, A.; Feld, J.; Haddad, A.; Gazzit, T.; Elias, M.; Higaz, N.; Aasi, M.; Quebe-Fehling, E.; Alarcon, I.; Kharouf, F.; Gertel, S.; Pel, S.; Nevo, S.; Devy, Z.; Furer, V.

Elkayam, O.; Eviatar, T.; Paran, D.; Levartovsky, D.; Kaufman, I.; Broyde, A.; Elalouf, O.; Polachek, A.; Feld, J.; Haddad, A.; Gazzit, T.; Elias, M.; Higaz, N.; Aasi, M.; Quebe-Fehling, E.; Alarcon, I.; Kharouf, F.; Gertel, S.; Pel, S.; Nevo, S.; Devy, Z.; Furer, V..

Aging Clinical and Experimental Research ; 34(SUPPL 1):S287-S287, 2022.

Article in English | Web of Science | ID: covidwho-2067995

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Aging Clinical and Experimental Research Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML